34MO Outcomes according to FGFR alteration types in patients with a solid tumour treated by a pan-FGRF tyrosine kinase inhibitor in phase I/II trials
Titel:
34MO Outcomes according to FGFR alteration types in patients with a solid tumour treated by a pan-FGRF tyrosine kinase inhibitor in phase I/II trials
Auteur:
Pobel, C.J. Facchinetti, F. Bahleda, R. Verlingue, L. Gazzah, A. Varga, A. Baldini, C. Champiat, S. Marabelle, A. Ningarhari, M. Geraud, A. Loriot, Y. Massard, C. Soria, J-C. Friboulet, L. Hollebecque, A.